… current status of allogeneic hemopoietic stem cell transplants (… size, as predictors of transplant
outcome. The choice of a … monitoring the disease after HSCT with donor chimerism, driver …

… , BM-CD34 + SC mixed chimerism appears here of high predictive value for relapse … -transplant
relapse. Moreover, full CD34 chimerism is a good indicator of successful hematopoietic …

… by chimerism status. The median time to chimerism assessment was 84 days post-transplant
(… of ATG AUC, these clinical factors may be useful surrogate predictors of T-cell chimerism. …

… A status of persistent mixed chimerism (PMC) of blood cells … kinetics are relevant for their
interpretation, relapse prediction … qPCR chimerism was also useful to monitor the efficacy and …

… has been used to prevent relapse after HSCT in leukemia … We gratefully acknowledge the
valuable cooperation of Center … Company for detection of chimerism status for our patients. We …

… may have greater predictive value for relapse than mixed chimerism (MC) in … stem cell
transplantation, followed closely by MFC-MRD. In contrast, chimerism status had limited predictive …

… Maintenance of complete chimerism status indicates … and metabolomics as predictive
biomarkers of patient response … The results represent a good correlation of the expected …

… molecular markers might prevent overt relapse, possibly through the strong graft-versus-tumor
effect of MF, and that the MC status provides a useful indicator for additional interventions […

… Allogeneic hemopoietic stem cell transplantation is the … of patients relapsing based on
disease risk and status at transplant. … chimerism has comparable sensitivity to RT-PCR with good …

… the status of the chimerism in a subset of hematopoietic cells, … [12], dPCR can be used
as a surrogate indicator of MRD in … useful for chimerism monitoring in the case of multiple-donor …